Charles C Homcy

Title: Charles C Homcy: Innovator in Heart Failure Research

Introduction

Charles C Homcy is a prominent inventor based in San Francisco, CA (US). He has made significant contributions to the field of medical research, particularly in understanding heart failure. His innovative work has led to the development of a transgenic model that aids in the testing of chemical compounds for treating or preventing heart failure.

Latest Patents

Homcy holds a patent for a transgenic model of heart failure. This invention relates to transgenic animals and methods for evaluating the effectiveness of various chemical compounds in combating heart failure. Specifically, he developed a transgenic mouse that selectively overexpresses Gαs approximately three-fold in the heart. Although the steady-state adenylyl cyclase activities remain unchanged, both the percentage of agonist high-affinity β-adrenergic receptors and the rate of catalyst activation are significantly increased. Furthermore, physiological and pathological studies have shown that chronic sympathetic stimulation can lead to adverse cardiac effects.

Career Highlights

Throughout his career, Charles C Homcy has focused on advancing the understanding of heart conditions and their treatments. His research has been pivotal in developing models that can simulate human heart failure, thereby providing valuable insights into potential therapies.

Collaborations

Homcy has collaborated with notable colleagues in the field, including Stephen F Vatner and Thomas R Wagner. These partnerships have enhanced the scope and impact of his research, contributing to advancements in cardiac health.

Conclusion

Charles C Homcy's innovative work in creating a transgenic model of heart failure exemplifies his commitment to improving medical research and treatment options. His contributions continue to influence the field and pave the way for future discoveries in heart health.